 | Up a level |
Li, Jing-Xin and Hou, Li-Hua and Meng, Fan-Yue and Wu, Shi-Po and Hu, Yue-Mei and Liang, Qi and Chu, Kai and Zhang, Zhe and Xu, Jun-Jie and Tang, Rong and Wang, Wen-Juan and Liu, Pei and Hu, Jia-Lei and Luo, Li and Jiang, Rong and Zhu, Feng-Cai and Chen, Wei (2017) Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: fi nal report of a randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Global Health, 5 (3). e324-e334. ISSN 0140-6736
